- Home
- Publications
- Publication Search
- Publication Details
Title
Repurposing of Drug Candidates for Treatment of Skin Cancer
Authors
Keywords
-
Journal
Frontiers in Oncology
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-01-09
DOI
10.3389/fonc.2020.605714
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Nanotechnology approaches in the current therapy of skin cancer
- (2020) Livia Neves Borgheti-Cardoso et al. ADVANCED DRUG DELIVERY REVIEWS
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cutaneous Squamous Cell Carcinoma: From Biology to Therapy
- (2020) Roberto Corchado-Cobos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Repurposing of drugs: An attractive pharmacological strategy for cancer therapeutics
- (2020) Anuradha Kirtonia et al. SEMINARS IN CANCER BIOLOGY
- A self-designed CpG ODN enhanced the anti-melanoma effect of pimozide
- (2020) Huijie Jia et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Basal Cell Carcinoma: A Comprehensive Review
- (2020) Emi Dika et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cytotoxic and proapoptotic effect of doxycycline – An in vitro study on the human skin melanoma cells
- (2020) Jakub Rok et al. TOXICOLOGY IN VITRO
- Deciphering the Molecular Landscape of Cutaneous Squamous Cell Carcinoma for Better Diagnosis and Treatment
- (2020) Andreea D. Lazar et al. Journal of Clinical Medicine
- An analysis of mitotic catastrophe induced cell responses in melanoma cells exposed to flubendazole
- (2020) K. Rudolf et al. TOXICOLOGY IN VITRO
- Metformin Treatment Suppresses Melanoma Cell Growth and Motility Through Modulation of microRNA Expression
- (2019) Hui-Wen Tseng et al. Cancers
- PD-1-siRNA delivered by attenuated Salmonella enhances the antimelanoma effect of pimozide
- (2019) Tiesuo Zhao et al. Cell Death & Disease
- The Anthelmintic Flubendazole Blocks Human Melanoma Growth and Metastasis and Suppresses Programmed Cell Death Protein-1 and Myeloid-Derived Suppressor Cell Accumulation
- (2019) Yue Li et al. CANCER LETTERS
- The effect of fenofibrate, a PPARα activator on toll-like receptor-4 signal transduction in melanoma both in vitro and in vivo
- (2019) N. Dana et al. Clinical & Translational Oncology
- Effects of topical piroxicam and sun filters in actinic keratosis evolution and field cancerization: a two-center, assessor-blinded, clinical, confocal microscopy and dermoscopy evaluation trial
- (2019) Marina Agozzino et al. CURRENT MEDICAL RESEARCH AND OPINION
- Active repurposing of drug candidates for melanoma based on GWAS, PheWAS and a wide range of omics data
- (2019) Ali Khosravi et al. MOLECULAR MEDICINE
- Pimozide suppresses cancer cell migration and tumor metastasis through binding to ARPC2, a subunit of the Arp2/3 complex
- (2019) Jiyeon Choi et al. CANCER SCIENCE
- Mebendazole as a Candidate for Drug Repurposing in Oncology: An Extensive Review of Current Literature
- (2019) Guerini et al. Cancers
- Repurposing of the anti-helminthic drug niclosamide to treat melanoma and pulmonary metastasis via the STAT3 signaling pathway
- (2019) Yongxia Zhu et al. BIOCHEMICAL PHARMACOLOGY
- Old wine in new bottles: Drug repurposing in oncology
- (2019) Michał Antoszczak et al. EUROPEAN JOURNAL OF PHARMACOLOGY
- Challenges and opportunities with drug repurposing: finding strategies to find alternative uses of therapeutics
- (2019) Alan Talevi et al. Expert Opinion on Drug Discovery
- Leflunomide: A promising drug with good antitumor potential
- (2018) Chunying Zhang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- The enhanced antitumour response of pimozide combined with the IDO inhibitor L‑MT in melanoma
- (2018) Huijie Jia et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes
- (2018) Chin-Hsiao Tseng JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression
- (2018) Ke Li et al. ONCOGENE
- Discovery of rafoxanide as a dual CDK4/6 inhibitor for the treatment of skin cancer
- (2018) Xinan Shi et al. ONCOLOGY REPORTS
- Flubendazole induces mitotic catastrophe and apoptosis in melanoma cells
- (2018) K. Čáňová et al. TOXICOLOGY IN VITRO
- Metformin exerts antitumor activity via induction of multiple death pathways in tumor cells and activation of a protective immune response
- (2018) Felipe V. Pereira et al. Oncotarget
- Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
- (2018) Ryszard Smolarczyk et al. Scientific Reports
- Propranolol for Off-label Treatment of Patients With Melanoma
- (2018) Vincenzo De Giorgi et al. JAMA Oncology
- Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
- (2018) Freddie Bray et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Metformin: Focus on Melanoma
- (2018) Emilie Jaune et al. Frontiers in Endocrinology
- Metformin increases antitumor activity of MEK inhibitor binimetinib in 2D and 3D models of human metastatic melanoma cells
- (2018) Oxana Ryabaya et al. BIOMEDICINE & PHARMACOTHERAPY
- Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods
- (2018) J. Ferlay et al. INTERNATIONAL JOURNAL OF CANCER
- Lidocaine-induced potentiation of thermal damage in skin and carcinoma cells
- (2018) Adam B. Raff et al. LASERS IN SURGERY AND MEDICINE
- An update on Drug Repurposing: Re-written saga of the drug’s fate
- (2018) Hema Sree GNS et al. BIOMEDICINE & PHARMACOTHERAPY
- The end of a dogma: the safety of doxycycline use in young children for malaria treatment
- (2017) Tiphaine Gaillard et al. MALARIA JOURNAL
- Drug Repurposing Approach Identifies a Synergistic Drug Combination of an Antifungal Agent and an Experimental Organometallic Drug for Melanoma Treatment
- (2017) Tina Riedel et al. MOLECULAR PHARMACEUTICS
- Targeted agents and immunotherapies: optimizing outcomes in melanoma
- (2017) Jason J. Luke et al. Nature Reviews Clinical Oncology
- The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth
- (2017) Kimberley Hanson et al. Oncotarget
- Inactivation/deficiency of DHODH induces cell cycle arrest and programed cell death in melanoma
- (2017) Lichao Liu et al. Oncotarget
- The repurposed anthelmintic mebendazole in combination with trametinib suppresses refractory NRASQ61K melanoma
- (2017) Cynthia M. Simbulan-Rosenthal et al. Oncotarget
- Itraconazole exerts its anti-melanoma effect by suppressing Hedgehog, Wnt, and PI3K/mTOR signaling pathways
- (2017) Guanzhao Liang et al. Oncotarget
- Digoxin Plus Trametinib Therapy Achieves Disease Control in BRAF Wild-Type Metastatic Melanoma Patients
- (2017) Arthur E. Frankel et al. NEOPLASIA
- Mebendazole in the treatment of melanoma: The role of Bcl-2 in predicting response and enhancing efficacy.
- (2017) N. A. Doudican et al. JOURNAL OF CLINICAL ONCOLOGY
- Long-term use of a new topical formulation containing piroxicam 0.8% and sunscreen: efficacy and tolerability on actinic keratosis. A proof of concept study
- (2016) Graziella Babino et al. CURRENT MEDICAL RESEARCH AND OPINION
- Liposomal systems as viable drug delivery technology for skin cancer sites with an outlook on lipid-based delivery vehicles and diagnostic imaging inputs for skin conditions'
- (2016) Naseem Akhtar et al. PROGRESS IN LIPID RESEARCH
- Synergistic effects of ion transporter and MAP kinase pathway inhibitors in melanoma
- (2016) Ugur Eskiocak et al. Nature Communications
- Doxycycline is an NF-κB inhibitor that induces apoptotic cell death in malignant T-cells
- (2016) Carolina V. Alexander-Savino et al. Oncotarget
- Drug repositioning and repurposing: terminology and definitions in literature
- (2015) Joris Langedijk et al. DRUG DISCOVERY TODAY
- The relevance of piroxicam for the prevention and treatment of nonmelanoma skin cancer and its precursors
- (2015) Elena Campione et al. Drug Design Development and Therapy
- Doxycycline: new tricks for an old drug
- (2015) David A. Barbie et al. Oncotarget
- Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: Treating cancer like an infectious disease
- (2015) Rebecca Lamb et al. Oncotarget
- HIF-1α pathway: role, regulation and intervention for cancer therapy
- (2015) Georgina N. Masoud et al. Acta Pharmaceutica Sinica B
- Fenofibrate induces apoptosis of triple-negative breast cancer cells via activation of NF-κB pathway
- (2014) Ting Li et al. BMC CANCER
- Structure-Based Virtual Screening for Drug Discovery: Principles, Applications and Recent Advances
- (2014) Evanthia Lionta et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Recent Advances in Drug Repositioning for the Discovery of New Anticancer Drugs
- (2014) Joong Sup Shim et al. International Journal of Biological Sciences
- Open-Label, Exploratory Phase II Trial of Oral Itraconazole for the Treatment of Basal Cell Carcinoma
- (2014) Daniel J. Kim et al. JOURNAL OF CLINICAL ONCOLOGY
- Metabolic Dysregulation in Melanoma: Cause or Consequence?
- (2014) R. Haq Cancer Discovery
- Nicotinamide enhances repair of ultraviolet radiation-induced DNA damage in human keratinocytes and ex vivo skin
- (2013) Devita Surjana et al. CARCINOGENESIS
- Medical approaches to non-melanoma skin cancer
- (2013) Giuseppe Micali et al. Expert Review of Anticancer Therapy
- Metformin Blocks Melanoma Invasion and Metastasis Development in AMPK/p53-Dependent Manner
- (2013) M. Cerezo et al. MOLECULAR CANCER THERAPEUTICS
- Skin Cancer: An Overview of Epidemiology and Risk Factors
- (2013) Randy Gordon Seminars in Oncology Nursing
- XIAP downregulation accompanies mebendazole growth inhibition in melanoma xenografts
- (2012) Nicole A. Doudican et al. ANTI-CANCER DRUGS
- Metformin, an Antidiabetic Agent Reduces Growth of Cutaneous Squamous Cell Carcinoma by Targeting mTOR Signaling Pathway†
- (2012) Sandeep C. Chaudhary et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- The Aryl Hydrocarbon Receptor Mediates Leflunomide-Induced Growth Inhibition of Melanoma Cells
- (2012) Edmond F. O’Donnell et al. PLoS One
- Fenofibrate
- (2011) Kate McKeage et al. DRUGS
- DHODH modulates transcriptional elongation in the neural crest and melanoma
- (2011) Richard Mark White et al. NATURE
- Albendazole sensitizes cancer cells to ionizing radiation
- (2011) Kirtesh Patel et al. Radiation Oncology
- Metformin inhibits melanoma development through autophagy and apoptosis mechanisms
- (2011) T Tomic et al. Cell Death & Disease
- Activation of c-Jun N-terminal kinase is essential for mitochondrial membrane potential change and apoptosis induced by doxycycline in melanoma cells
- (2010) Jiunn-Min Shieh et al. BRITISH JOURNAL OF PHARMACOLOGY
- Itraconazole, a Commonly Used Antifungal that Inhibits Hedgehog Pathway Activity and Cancer Growth
- (2010) James Kim et al. CANCER CELL
- Review: Ultraviolet radiation and skin cancer
- (2010) Deevya L. Narayanan et al. INTERNATIONAL JOURNAL OF DERMATOLOGY
- Topical Treatment of Actinic Keratoses with Piroxicam 1% Gel
- (2009) Elena Campione et al. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY
- Doxycycline inhibits the adhesion and migration of melanoma cells by inhibiting the expression and phosphorylation of focal adhesion kinase (FAK)
- (2009) Tao Sun et al. CANCER LETTERS
- Alterations in Skin Immune Response Throughout Chronic UVB IrradiationâSkin Cancer Development and Prevention by Naproxen
- (2009) Daniel H. González Maglio et al. PHOTOCHEMISTRY AND PHOTOBIOLOGY
- IL-12 Deficiency Exacerbates Inflammatory Responses in UV-Irradiated Skin and Skin Tumors
- (2008) Syed M. Meeran et al. JOURNAL OF INVESTIGATIVE DERMATOLOGY
- Mebendazole Induces Apoptosis via Bcl-2 Inactivation in Chemoresistant Melanoma Cells
- (2008) N. Doudican et al. MOLECULAR CANCER RESEARCH
- PPAR agonist fenofibrate suppresses tumor growth through direct and indirect angiogenesis inhibition
- (2008) D. Panigrahy et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started